Email updates

Keep up to date with the latest news and content from BMC Biology and BioMed Central.

Journal App

google play app store
Open Access Commentary

Appetite for destruction: the inhibition of glycolysis as a therapy for tuberous sclerosis complex-related tumors

Alfredo Csibi and John Blenis*

Author Affiliations

Department of Cell Biology, Harvard Medical School, 240 Longwood Ave, Boston, MA 02115, USA

For all author emails, please log on.

BMC Biology 2011, 9:69  doi:10.1186/1741-7007-9-69

Published: 21 October 2011


The elevated metabolic requirements of cancer cells reflect their rapid growth and proliferation and are met through mutations in oncogenes and tumor suppressor genes that reprogram cellular processes. For example, in tuberous sclerosis complex (TSC)-related tumors, the loss of TSC1/2 function causes constitutive mTORC1 activity, which stimulates glycolysis, resulting in glucose addiction in vitro. In research published in Cell and Bioscience, Jiang and colleagues show that pharmacological restriction of glucose metabolism decreases tumor progression in a TSC xenograft model.

See research article: webcite